Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant

Clinical trial NCT03925532 · COMPLETED

Trial details

NCT number: NCT03925532
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Stem Cell Transplantation Recipient Osteopenia Osteoporosis

Start date: 2019-12-19
Primary completion: 2022-11-16
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.